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Since the year 2000, the Defense and Veterans Brain Injury Center reported 414,000 
documented cases of traumatic brain injuries (TBIs) among individuals serving in the United 
States Armed Forces (Defense and Veterans Brain Injury Center, 2020). Traumatic events to the 
head as a result from car accidents, falls, explosions, and gunshot wounds can lead to a 
disruption of normal cognitive functioning. Roughly 80% of diagnosed TBIs are mild in nature, 
commonly referred to as concussions, and can range from mild, moderate, severe, and 
penetrating (O’Neil et al., 2013). However due to the difficulty of diagnosing a TBI most cases 
go undocumented, or patients do not seek treatment. TBIs that are left untreated can result in 
progressive neurostructural damage which can lead to the development of dementia-related 
diseases as well as psychological problems such as post-traumatic stress disorder (PTSD) 
(McKee et al., 2014). The physical and mental health conditions that can result from sustaining a 
TBI can drastically impact the lives and families of those injured veterans. With an estimated 8 
million adults suffering from PTSD each year as per the National Center for PTSD (2020), 
researchers must understand how to utilize the linkage between a TBI and PTSD in order to 
appropriately prevent progressive neurodegeneration and any associated psychological problems 
(Gradus, 2019).   
Previous studies have shown evidence that both single-incidence and repetitive mild TBIs 
(mTBIs) can lead to atrophy of the grey and white matter in the brain and can promote the 
acceleration of neurodegeneration in the brain (Gradus, 2019).This chronic neurodegeneration 
can pose an increased risk for the development of progressive neurodegenerative diseases such 




Chronic Traumatic Encephalopathy (CTE) (Gradus, 2019; National Center for PTSD, 2020). 
Accompanying neurodegeneration are behavioral changes, executive dysfunction, memory loss, 
and cognitive impairments (DePalma et al., 2018). Researchers have begun to find associations 
between PTSD and TBI as a result of the disruptions to certain neuropathways from the 
amygdala and orbitofrontal cortex (DePalma et al., 2018; McKee et al., 2014). This capstone 
project is a literature review of the neurostructural and cognitive-behavioral changes that result 
from traumatic brain injuries. The research provided in this paper explores the connections 
between neurostructural damage and progressive neurodegenerative diseases such as 
Alzheimer’s Disease (AD), FTLD, and CTE. Psychological effects that stem from sustaining a 
TBI including post-traumatic stress disorder (PTSD) and the increased risk for suicide and self-





Traumatic Brain Injury 
The Defense and Veterans Brain Injury Center (DVBIC) defines a traumatic brain injury 
(TBI) as a “blow or jolt to the head that disrupts normal functioning of the brain” (Defense and 
Veterans Brain Injury Center, 2020). Car accidents, falls, explosions, and gunshot wounds are all 
common traumatic events that can lead to an individual, whether civilian or soldier, sustaining a 
TBI. Sustaining an TBI while serving in the military is unpredictable and spontaneous, yet blast 
exposures from bombs, grenades, and improvised explosive devices (IEDs) remain the most 
common cause of TBIs sustained in combat (McKee et al., 2014). One group of researchers 
found that in U.S. troops deployed to Iraq and Afghanistan during Operation Iraqi Freedom 
(OIF), Operation Enduring Freedom (OEF), and Operation New Dawn (OND), the occurrence of 
blast related TBIs varied from 15-23%, affecting almost 400,000 troops (McKee et al., 2014; 
Rosenfeld et al., 2013). Additionally, another group of researchers screened 1 million veterans of 
the 2.6 million serving from 2007 through 2015. Roughly 20% of the 1 million veterans screened 
positive on questions pertaining to TBI-sustaining events, immediate symptoms, new or 
worsening symptoms, and current symptoms. Of the positively screened veterans, almost 10% 
were positive for a concussion/mild TBI. When these results are compared to the civilian world, 
the prevalence among civilians is greatly decreased. In a survey of 57,392 civilian trauma cases 
in the United States, 89 (0.2%) where blast-related injuries, demonstrating how rare traumatic 
brain injuries are to the general population (Elder et al., 2010). The increasing prevalence of 
TBIs in combat situations requires an immediate concussive assessment in order to prevent and 




soldiers for possible concussive events, many do not self-report the incidences thus leading to 
difficult diagnoses.  
BACKGROUND 
TBIs remain one of the most difficult brain injuries to diagnosis correctly among soldiers 
and it is one of the least understood in terms of the disrupted mechanisms and pathways (McKee 
et al., 2014). U.S. soldiers can experience reoccurring and progressive long-term effects after 
sustaining a TBI, with resulting cognitive, behavioral, and physiological changes. Common self-
reported symptoms by U.S. soldiers include headaches, cognitive dysfunctions, attention 
difficulties, and impaired balance, and all will vary with the severity of the sustained TBI. TBI is 
considered one of the “invisible” wounds sustained during military service due to the lack of 
external evidence for head or brain injuries. Until imaging and questionaries are obtained 
through a medical care provider can a TBI diagnosis be given. Diagnosed traumatic brain 
injuries are classified on a scale of mild, moderate, and severe. The Department of Defense 
(DOD) and the Department of Veteran Affairs (VA) use 6 criteria in their diagnosis of a TBI, as 
shown in Table 1: structural imaging, loss of consciousness (LOC), alteration of consciousness 
(AOC), post-traumatic amnesia (PTA), and the Glasgow Coma Scale (GCS) (shown in Table 2). 
(O’Neil et al., 2013; Rosenfeld et al., 2013).  




Table 2. Glasgow Coma Scale (recreated using CDC guidelines)  
 
A mild TBI (mTBI) is defined as having normal structural imaging, LOC lasting less than 
30 minutes, AOC lasting less than 24 hrs, PTA lasting less than 1 day, and a GCS score of 13 to 
15. A moderate TBI is defined as having normal or slightly abnormal structural imaging, LOC 
lasting 30 mins up to 24 hrs, AOC lasting at least 24h hrs, PTA lasting from 1 day to 1 week, and 
a GCS score of 9 to 12. A severe TBI is defined as having normal or abnormal structural 
imaging, LOC lasting more than 24 hrs, AOC lasting more than 24 hrs, PTA lasting at least 1 
week, and a GCS score less than 9. While a clinical diagnosis exists, TBIs remain one of the 
most difficult brain injuries to diagnosis correctly among soldiers and the acute and long-term 
effects have been a poorly researched and explored (McKee et al., 2014). U.S. soldiers can 
experience persistent and progressive long-term effects after sustaining a TBI, with resulting 
cognitive, behavioral, and physical changes. Commonly self-reported symptoms by U.S. combat 
veterans include headaches, forgetfulness, poor concentration, and anxiety. These symptoms 
typically self-resolve over the course of a few days to weeks, however 10-20% of soldiers report 
continued unresolved problems (Vasterling et al., 2009). These cognitive dysfunctions, attention 
BEHAVIOR RESPONSE   SCORE 
Eye Opening Response Spontaneously  4 
To speech 3 
To pain 2 
None 1 














difficulties, impaired balance, and physiological changes all will vary with the severity and 
classification of TBI.  
Although most neurological symptoms are subjective in nature due to veterans self-
reporting to their primary care physicians, there are two initial assessments used to for any 
suspected TBIs. The Military Acute Concussion Evaluation (MACE) is an initial mental status 
assessment given to veterans who may or may not have been involved in an acute concussive 
event (Air Force Center of Excellence for Medical Multimedia). The assessment contains 4 
sections: a concussion screening, a cognitive exam, a neurological exam, and a symptom 
screening. The initial concussion screening looks to identify information about the sustained 
concussive event, whether there was loss of consciousness, alteration of consciousness, and/or 
post-traumatic amnesia. The cognitive exam focuses on orientation, memory, and recall of the 
veteran post concussive event. The neurological exam tests for pupil responses to light, speech 
ability and comprehension, grip strength, and balance. The last section involves symptom 
screening, which screens veterans for the common complaints of headaches, dizziness, impaired 
memory, balance problems, nausea/vomiting, tinnitus, and concentration. MACE should be the 
initial assessment given to any U.S. soldier who has experienced a concussive event within the 
first 24 hours of the event happening. For those combat veterans who are experiencing symptoms 
past that window of time or those who have screened positive on the MACE, they are given the 
Comprehensive Traumatic Brain Injury Evaluation (CTBIE) through the VHA healthcare 
system. The CTBIE is conducted by a TBI specialist who gathers an in-depth history of the 
patient’s symptoms, the concussive event, review of body systems, physical exam, and 
administers the Neurobehavioral Symptom Inventory (NSI). A formal diagnosis can be made, 




2016). Treatment options and TBI management will be discussed later in the Discussion portion 
of this paper.  
As mentioned previously, blast related TBIs are the leading cause of traumatic brain 
injuries among U.S. combat veterans, with blast-related mTBIs as the most common form 
affecting military personnel (McKee et al., 2014). McKee et al. (2014) reports that 60% of TBIs 
in the combat setting were of blast-related origin, with over 80% of those blast-related incidences 
resulting in a mTBI diagnosis. A mild TBI (mTBI), commonly referred to as an acute injury or 
simply a concussion, is typically caused by an impactful force, either directly or indirectly, to the 
head, face, and/or neck region. A blast related TBI is broken down into four components: 
primary, secondary, tertiary, and quaternary (Rosenfeld et al., 2013). Primary is characterized by 
the initial transmission of the blast wave through the skull into the brain. Secondary refers to any 
projectiles penetrating through the skull into the brain such as shrapnel or bullets. Tertiary is any 
acceleration, deceleration, or rotational effects on the brain. Quaternary involves other injuries to 
the head, face, neck and respiratory system such as any chemical or thermal injuries. The 
primary component of a blast related TBI is involved with all severities of a TBI: mild, 
moderate, and/or severe. Secondary, tertiary, and quaternary components are associated with 
only moderate and severe TBIs. Blast related TBIs result in the transmission of acoustic waves 
through the brain tissue. The blast waves can induce the brain tissue and surrounding blood 
vessels to expand and contract, resulting in tears and breakage. These tears and damages can lead 
to cerebral edema, intraparenchymal and subarachnoid hemorrhages, delayed vasospasms, 
cerebral ischemia, herniations, and aneurysms (McKee et al., 2014; Rosenfeld et al., 2013). 
Moderate and severe TBIs can also result in damages and eventual atrophy of the grey and white 




2014). Diffuse axonal injuries associated with moderate and severe TBIs cause the brain to 
elongate and misshape due to rapid acceleration, deceleration, and rotational forces from a blast. 
Axons that make up the neural circuitry in the brain are extremely susceptible to injury and 
damage, so when the brain elongates and misshapes as a result of the blast, axons become 
damaged. These microstructural changes in the white and grey matter and fiber tracts can result 
in severe neurological and physiological changes. The microvasculature system is compromised 
which leads to a disruption in the blood-brain barrier as well as focal cortical hypoperfusion 
(McKee et al., 2014). Additionally, there is a rapid uncontrolled release of neurotransmitters 
such as glutamate, changes within the sodium (Na+) channels and sodium-potassium (Na+/K+) 
pumps, massive influx of calcium (Ca2+) ions, efflux of potassium (K+) ions, and an increase in 
glucose metabolism (McKee et al., 2014).  
The most widely used diagnostic definition of a TBI, taken from the Department of 
Defense and Department of Veterans Affairs, states that normal structural imaging on CT and 
MRI scans may or may not be present based on the severity of the TBI. Mild TBIs and some 
moderate TBIs typically do not show any abnormalities on imaging scans, while severe TBIs 
may show abnormalities. CT scans are the preferred choice during the first 24 hours after 
sustaining a traumatic brain event. CT scans are able to detect any early bleeds and any cerebral 
or bony pathology (Lee & Newberg, 2005). However, after 24 hours MRI scans are the preferred 
choice as they are able to detect any hematomas, axonal injuries, or small neuronal damage (Lee 
& Newberg, 2005). The pathophysiology of any blast related TBI is distinctive and varies across 
individuals depending on the blast energy, distance from the initial blast, body orientation, use of 




these blast related effects play an important role in the pathological presentation of each TBI for 
each individual veteran.  
As mentioned above in the TBI diagnosis, most patients present with normal structural 
imaging after sustaining a TBI. The use of MRI to detect any brain abnormalities has been 
proven unreliable within the first 24 hours due to scans showing the absence of abnormalities 
when in fact there may be some present (MacDonald et al., 2011). When T2 MRI scans do show 
abnormalities, common findings include cerebral microhemorrhages, contusions, gliosis, and 
encephalomalacia (Riedy et al., 2016). However, the common presentation of no visible damage 
from CT or MRI scans does not mean there is an absence of any abnormalities (Elder et al., 
2010). Additional scans and tests must be done in order to determine the extent of the brain 
injury. Diffusion tensor imaging studies have shown that soldiers who have sustained a TBI or 
currently experience PTSD have disrupted white matter integrity (Davenport et al., 2015). 
Diffusion tensor imaging (DTI) has become a widely popular diagnostic tool to determine the 
severity of neuronal damage. DTI is a type of magnetic resonance imaging (MRI) that is 
extremely sensitive to the diffusion rate of water in brain cells and tissue, measuring the 
structural integrity of the surrounding white matter (Taber et al., 2015). Water diffuses through 
grey matter at similar rates in every direction yet will diffuse differently through white matter 
depending on the surrounding structure. The direction of water diffusion within the white matter 
is controlled and bound by certain physical boundaries such as myelin and axon membranes 
(Chanraund et al., 2010). This causes the water to diffuse more easily down the controlled 
direction of the axon compared to perpendicularly, making the diffusion highly angiotrophic. 
Thus, when there are structural and integrity changes within the white matter, the rate of 




anisotropy. This allows researchers to pinpoint and detect any subtle neurostructural changes 
within the white matter and fiber tracts. Neuroanatomy changes as a result of TBIs have been 
found in the cingulum, uncinate fasciculus, anterior and posterior limbs of the internal capsule, 
cerebellar peduncles, and the genu of the corpus callosum (Petrie et al., 2014).  
Another useful tool that has been proven to detect changes within the neuronal axons is 
amyloid precursor protein immunohistochemistry (McKee & Robinson, 2014). This type of test 
uses amyloid precursor proteins to visualize traumatic axonal injuries (TAIs) around small blood 
vessels in the corpus callosum, fornix, subcortical U-fibers, and the cerebellum. This test looks 
for accumulations of hyperphosphorylated tau (p-tau) in the form of neurofibrillary tangles 
(NFTs) and hemosiderin-laden macrophages (McKee & Robinson, 2014). Researchers have 
specifically linked these NFTs and hemosiderin-laden macrophages to axonal injuries, breaches 
of the blood-brain barrier, and neuroinflammation, which are all extremely important 
determiners for soldiers sustaining a TBI.  
Neuroanatomy and Neural Pathways 
 Blast-related TBIs, whether mild, moderate, or severe, all can change the composition of 
the neuroanatomy in the brain. The cerebrum, amygdala, hippocampus, orbitofrontal cortex, 
frontal lobe, and temporal lobe, to name a few, are all heavily impacted as a result of sustaining a 
traumatic brain injury. Injury to these structures can lead to downstream effects causing memory 
problems, cognitive defects, behavioral abnormalities, and neuronal damage. The neuronal 
pathways and connections that allow humans to function as their baseline “normal” become 
disrupted. The limbic system is the epicenter for memory and emotion processing. The structures 
that comprise the limbic system provide the link between our emotions and our drive-related 




Shetty, 2005; Vanderah & Nolte, 2018). It is a grey area in terms of the structures and boundaries 
within the limbic system, which include the cingulate gyrus, hippocampus, amygdala, septal 
nuclei, hypothalamus, and olfactory bulbs. While all of these structures are vulnerable to 
damage, the important TBI-related neuroanatomy includes the amygdala and hippocampus. 
The amygdala is the control center for emotional responses, especially fear. Two kinds of 
sensory inputs project to the amygdala for processing and responses: general senses (such as 
taste, touch, smell, visual, and sounds) and physical and emotional senses. These inputs into the 
amygdala are then processed and projected outward to other surrounding structures such as the 
hypothalamus, septal nuclei, hippocampus, olfactory regions, basal ganglia, and other cerebral 
cortical structures. These projections allow the amygdala to bridge the connections between the 
“perception of objects and situations with the appropriate emotional response” (Vanderah & 
Nolte, 2018). Typically, these emotional responses relate to fear or danger, but that is not always 
the case. Projections from the thalamus allow the amygdala to process things in the outside 
world, while projections from other limbic structures and the hypothalamus allow the amygdala 
to process the body’s current emotional and physiological condition. Outputs from the amygdala 
utilize these inputs to tell other structures how to respond. Outputs for emotional responses are 
sent to the hypothalamus, brainstem, and ventral striatum. Outputs for emotional memories and 
storage are sent back through the limbic system and hypothalamus, while outputs involving 
heightened awareness are sent to sensory cortices (Vanderah & Nolte, 2018).  
Normal activation of the amygdala results in attentive fear. We typically stop what we are 
doing in a frozen state, become very in-tune to our surroundings, and then experience aggression 
with either fight or flight responses via our sympathetic nervous system. Activation of the 




blood vessel dilation in the muscles. These primal responses allow us to react to a perceived 
threat, increasing our odds in survival. Since the amygdala sends projections to the hippocampus, 
situations that heavily activate the amygdala will tell the hippocampus to store memories of the 
events in order to remember next time a similar situation arises. Ratliff et al. (2019) found 
significant neurostructural changes to the basolateral amygdala during research studies on rats 
sustaining blast related TBIs (Ratliff et al., 2019). By mimicking the blast explosions as those 
found overseas in combat zones, the researchers were able to expose rats to these blasts to 
determine the traumatic effects on the amygdala. The researchers found a significant increase in 
the number of dendritic branching, dendritic spine densities, and increased signaling within the 
amygdala. The researchers hypothesized that the increased signaling within the amygdala can be 
attributed to increased feelings of fear and hyperarousal, which can overtime lead to the 
development of PTSD (Ratliff et al., 2019).  
The hippocampus is another limbic structure which is extremely important to traumatic 
events and how we as humans process our responses to the situation. The hippocampus is a 
structure found in the medial aspect of the anterior temporal lobe which resembles a seahorse 
shape (Felten & Shetty, 2011). The functional aspect of the hippocampus is memory formation, 
specifically consolidating short-term memories into long-term storage. The hippocampus 
contains a wide range of connections throughout the brain and within itself, with information 
going to regions of the neocortex, temporal lobe and additional limbic structures such as the 
amygdala (Felten & Shetty, 2011). Memory formation and storage involves explicit memory, 
which are memories involving objects, stimuli, and information that is easily recalled and known 
(Felten & Shetty, 2011). This includes information on specific personal events, dates, and facts. 




on the hippocampus and rely on other surrounding brain structures. Storage of explicit memories 
are dependent on the hippocampus and other structures in the medial temporal lobe. Within the 
hippocampus are CA1 neurons containing pyramidal cells (Felten & Shetty, 2011). These 
hippocampal cells are vulnerable to damage and apoptosis which can lead to long-term cognitive, 
learning, and memory problems. Damage to these structures can lead to memory consolidation 
problems, affecting immediate and short-term memories, confusion, and disorientation (Felten & 
Shetty, 2011). Aungst et al. (2014) found substantial neuronal cell loss in both the ipsilateral and 
contralateral hippocampus in patients with repeated mTBIs. Additionally, they found a 
significant increase in the number of activated microglial cells, potentially serving as both 
neuroprotective and neurotoxic agents (Aungst et al., 2014). The neuronal cell loss and increased 
microglial presence leads to deficits in hippocampal functioning and a disruption in the synaptic 
transmission between cells, something commonly found in chronic neuroinflammation and 
neurodegeneration. This will play a role in the next section in regard to certain 
neurodegenerative diseases involving memory deficits.  
Wright et. al (2017) demonstrated in their research that rats sustaining a blast-related 
traumatic brain injury can lead to progressive neuronal damage and eventual neuronal loss. The 
researchers linked their results from rats to soldiers sustaining TBIs while in combat. They 
hypothesized that a TBI can lead to progressive atrophy of the motor cortices with degeneration 
of the corticospinal tracts (Wright et al., 2017). Wright et al. (2017) also found a reduction in 
neurons with increased TDP-43 in the motor cortex, reduced spinal cord motor neurons, and 
increased expression of muscle atrophy markers. The atrophy of the motor cortex due to reduced 




progressive neurodegenerative diseases such as Alzheimer’s Disease, ALS, CTE, and FTLD. 
Specific neurodegenerative diseases will be discussed in the section below.  
Progressive Neurodegenerative Diseases 
 Traumatic brain injuries, whether mild, moderate, or severe, can result in a complete 
disruption in the normal processing of brain structures. Through repeated TBI exposures or 
increased severity, these brain injuries can lead to progressive pathophysiological presentations 
which include neuronal apoptosis, oxidative stress, neuroinflammation, diffuse axonal injuries, 
and excitotoxicity (Blennow et al., 2012). This is extremely concerning for those individuals 
serving within the United States military who are constantly at risk for TBI exposure, especially 
blast-related, while overseas. These individuals are at a high risk for sustaining a TBI, which puts 
them at an even higher risk for developing or triggering neurodegenerative diseases and PTSD 
(Omalu et al., 2011). McKee and Robinson (2014) found evidence in their studies that even a 
single TBI can lead to long-term gray and white matter atrophy, accelerate any present 
neurodegeneration, and can increase the risk of Alzheimer’s Disease, Parkinson’s Disease, 
Chronic Traumatic Encephalopathy, and motor neuron diseases such as ALS. They additionally 
found that those individuals sustaining a moderate to severe TBI were at a 50% increased risk for 
developing dementia-related diseases (McKee & Robinson, 2014). Due to these increased risks, 
TBIs, especially moderate and severe, have become an extremely important risk factors for 
progressive neurodegenerative diseases (Shahim et al., 2020). The connections between TBIs 







 Researchers have determined that TBIs are one of many risk factors for late-life 
dementias, including Alzheimer’s Disease (AD) (Mortimer et al., 1991). The relationship 
between this type of head trauma and Alzheimer’s Disease has been established, yet it is very 
difficult for physicians to determine without looking at the neuropathology of the patient 
(Daneshvar et al., 2011). There is however a correlation with veterans having a history of 
traumatic brain injuries and higher prevalence of Alzheimer’s-disease pathology (Danesvhar et 
al., 2011). The pathology of Alzheimer’s Disease within veterans diagnosed with TBIs are 
similar to civilian patients with the AD diagnosis. There is a presence of amyloid-ß neuritic 
plaques and phosphorylated-tau (p-tau) neurofibrillary tangles (NFTs) (McKee et al., 2013). 
These amyloid-ß proteins are formed from amyloid-precursor proteins by ß-secretase and gamma 
secretase (Blennow et al., 2012). Amyloid-precursor protein has been found to be upregulated as 
a response to traumatic brain injuries, which in turn accumulate around the neurons and axons in 
the brain as a result of the axonal damage (Blennow et al., 2012).  
Parkinson’s Disease 
 Parkinson’s Disease is another progressive neurodegenerative disease that has been 
connected to higher prevalence due to a history of traumatic brain injuries. Bower et al (2003) 
determined that the association between traumatic brain injuries and development of Parkinson’s 
Disease varies by the severity of TBI sustained. There is a similar but different neuropathology 
to Alzheimer’s Disease with instead a presence of alpha-synuclein-positive Lewy bodies within 
the brainstem (McKee et al., 2013). These alpha-synuclein proteins are the primary building 





Frontotemporal Lobar Degeneration 
 Frontotemporal Lobar Degeneration (FTLD) is a progressive neurodegenerative disease 
characteristic of atrophy of the frontal and temporal lobes in the brain, that can lead to a type of 
dementia called frontotemporal dementia (Heyburn et al., 2019). Frontotemporal dementia 
(FTD) is one of the most common types of dementia found in individuals under the age of 65 and 
has an even higher occurrence within the veteran community (Heyburn et al., 2019). Three types 
of FTD exist including behavior, non-fluent, and semantic. FTD-Behavior involves behavior 
changes such as disinhibition, apathy, and impulsivity. FTD-Non-Fluent involves difficulty in 
speech production, while FTD-Semantic involves impaired speech comprehension (Heyburn et 
al., 2019). Those veteran patients with a history of TBIs were 3.33 times more likely to develop 
FTD and had earlier ages of onset for symptoms compared to patients with no previous TBI 
diagnoses (Heyburn et al., 2013). The neuropathology of FTLD involves an accumulation of 
phosphorylated-tau (p-tau) and TDP-43, a DNA and RNA binding protein that controls the 
expression of many different types of genes (McKee et al., 2013). The TDP-43 proteins become 
hyperphosphorylated and ubiquitinated, breaking off into pathological fragments that accumulate 
in the cytoplasm. Studies have shown that in as little as one sustained TBI, accumulation of the 
TDP-43 fragments can occur leading to significant changes in cognition and behavior (Heyburn 
et al., 2019).  
Chronic Traumatic Encephalopathy 
 Chronic Traumatic Encephalopathy (CTE) is a progressive neurodegenerative disease 
that is characterized by widespread accumulation of hyperphosphorylated-tau (p-tau) as 
neurofibrillary tangles (NFTs), typically caused by single, episodic, or repetitive trauma to the 




brain such as atrophy of the cerebral cortex, medial temporal lobe, thalamus, and hypothalamus 
(McKee & Robinson, 2014). In addition to widespread atrophy, there is enlargement of the 
lateral and third ventricles and thinning of the corpus callosum and septum pellucidum (McKee 
& Robinson, 2014). Structural changes within the limbic system such as damage to the 
hippocampus, medial temporal lobe, and fornix, lead to behavioral changes, executive 
dysfunction, memory loss, and other cognitive impairments (McKee & Robinson, 2014). These 
behavioral and cognitive changes typically will begin insidiously but will progress over years 
and have detrimental effects. There are currently four symptom stages of CTE that range from 
headaches and loss of attention (Stage I) to more severe symptoms such as executive dysfunction 
(Stage III) and dementia (Stage IV) (McKee et al., 2013). Researchers have shown that 
symptoms typically will be present 8-10 years after sustaining a TBI (McKee & Robinson, 
2014). Repetitive TBIs can increase the development of the disease, with researchers finding 
cases of CTE in veterans of the Iraq and Afghanistan conflicts who had been exposed to 
explosive blasts (McKee & Robinson, 2014). Neuropathological studies of postmortem brains 
from veterans with a history of TBIs and blast exposures showed CTE that was consistent with 
NFL athlete CTE case studies, further demonstrating the link between TBIs and this progressive 
neurodegenerative disease. (Goldstein et al., 2012).  
Cognitive Behavioral Changes 
 The effects of traumatic brain injuries within the veteran community go beyond the 
structural and neuronal damages that occur. When neurological structures in the brain are 
damaged, upstream and downstream pathways become disrupted leading to a wide range of 
cognitive and behavioral changes. Structural damage and neuronal loss around the inferior 




impulsivity, explosivity, and increased aggression (McKee et al., 2013). Others have self-
reported poorly controlled anger, social isolation issues, attention difficulty, poor concentration, 
paranoia, insomnia, and depression (McKee & Robinson, 2014). Structural damage to the 
subcallosal and inferior orbital frontal cortex and brainstem has been shown to lead to 
depression, mood lability, headaches, and suicidality (McKee & Robinson, 2014; McKee et al., 
2013). As mentioned above, damage to the limbic structures results in numerous impairments in 
learning and memory such as amnesia, mental confusion, and speech hesitancy. These behavioral 
and cognitive changes, executive dysfunction, and memory loss are all characteristic to patients 
who have sustained traumatic brain injuries. 
Polytrauma Clinical Triad 
 The Polytrauma Clinical Triad was developed as a way to categorize the co-occurrences 
of chronic pain, Post-Traumatic Stress Disorder (PTSD), and TBIs within the veteran community 
(Blakey et al., 2018). These three co-occurrences have been associated with suicidal ideation, 
violent impulses, increased pain intensity, drug abuse, and Major Depressive Disorder (Blakey et 
al., 2018). Since the War on Terror began in 2001, suicide and self-harm has become an 
increasingly major issue and concern among the veteran community. In a 2010 report by the 
Department of Defense, suicide rates in all the service branches increased from roughly 10 per 
100,000 people in 2001 to 20 per 100,000 people in 2010 (U.S. Department of Defense, 2010). 
These rates continue to increase as veterans are increasingly exposed to the dangers of war and 
blast exposures.  
The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition categorizes 
Post-Traumatic Stress Disorder (PTSD) as a trauma-and-stressor-related disorder that comes as a 




The diagnostic criterion for PTSD is shown in Table 3, which shows the criteria for adults, 
adolescents, and children over the age of 6. Within the veteran community, diagnosis for PTSD 
results from the initial exposure to the traumatic events of combat and subsequent symptoms 
within 6 months according to the ICD-10 (Substance Abuse and Mental Health Services 
Administration, 2014). PTSD is characterized by frontal lobe dysfunction, executive dysfunction, 
impulsivity, emotional lability, disinhibition, and impairments in attention and memory, 
specifically working memory (Vasterling et al., 2009). These presiding symptoms come as a 
result of damage to key structures within the brain including the prefrontal cortex, amygdala, 
hippocampus, and white matter damage within the fronto-striatal fibers, fronto-limbic circuits, 
fronto-parieto-occipital fibers, brainstem fibers, and callosal fibers (Elder et al., 2010; Yeh et al., 
2014). Sustaining a traumatic brain injury can damage these functional structures and further 
increase the risk for development of PTSD symptoms, especially within the veteran community 
(Elder et al., 2010). In addition to structural damage, PTSD has been found to be associated with 
high white matter integrity within the bilateral anterior thalamic radiations, cingulum, and 
frontotemporal tracts (Davenport et al., 2015).  
Post-Traumatic Stress Disorder (PTSD) has been shown to be associated with TBIs and 
suicide risks within the veteran community (Hoge et al., 2008). Loignon et al. (2020) has found 
that the combination of combat military settings overseas and TBI diagnoses present far greater 
risks for developing PTSD in veteran soldiers. They found that sustaining a traumatic brain 
injury can lead to an initial PTSD diagnosis, severe PTSD symptoms compared to non-TBI 
veterans, and a longer PTSD remission, with a roughly 16% lifetime prevalence in the military 
community (Gates et al., 2012; Loignon et al., 2020). This increased risk is due to the overlap of 




have been shown to be associated with neuropsychological impairments, ranging from problems 
with attention, learning, memory, and executive function (Vasterling et al., 2009). Unlike TBI-
related impairments that can show up shortly after the traumatic event, PTSD symptoms take a 
slower approach that can last years longer than TBI symptoms (Vasterling et al., 2009). 
However, the context and location in which the traumatic brain injury was sustained is thought to 
be determinant of how PTSD develops and progresses within an individual (Vasterling et al., 
2009). The neuropsychological processes that occur immediately after sustaining a TBI affects 
the progressive development of PTSD. Within 24 hours after sustaining a TBI, there is an 
emotional response formed to the traumatic event and short-term consolidation of memories, 
including trauma memory (Vasterling et al., 2009). Fear conditioning also occurs, activating 
certain biological pathways in response to stress, such as the HPA axis, autonomic nervous 
system, cell-mediated immunity, and sleep/wake cycles (Bryant, 2001). These consolidated 
traumatic memories and emotional responses are then later resurfaced due to certain triggers or 
events as PTSD progresses in an individual.  
 Hoge et al. (2008) found a 44% prevalence in PTSD symptoms in 2525 soldiers who 
screened positive for sustaining an mTBI, further suggesting the strong association between 
mTBI and PTSD. In another study looking at veterans from Operation Iraqi Freedom, Operation 
Enduring Freedom, and Operation New Dawn, 80% of soldiers exposed to a blast-related TBI 
with early symptoms of CTE were also diagnosed with PTSD (McKee & Robinson, 2014). 
These types of combat injuries play an increased role in PTSD and long-term health effects 
including cardiovascular diseases and neurological disorders (Schneiderman et al., 2008). With 
the association between TBI and PTSD, it is however clinically difficult to determine whether 




2009). When looking at TBI and PTSD, one can view each as the opposite end of a spectrum. On 
the TBI end, there is organic brain disease and structurally damaged areas of the brain, while on 
the PTSD end there is psychologically reactive damage (Elder et al., 2010). Table 4 displays the 
differences among PTSD and TBI symptoms. While each end of the spectrum may have their 
own differences, the middle of the spectrum allows for heavy overlap in physiological and 
psychological symptoms. These overlapping changes in the brain can lead to disrupted neural 
connections and pathways that can present with behavioral and cognitive dysfunction. Research 
is still evolving, although there is recent evidence that TBIs are more highly associated with 
PTSD than any other type of injury sustained in combat (Hoge et al., 2008).  











































 A literature review was completed in order to describe and detail the complexities behind 
traumatic brain injuries and their role in physiological and psychological changes within U.S. 
combat veterans. Two major TBI databases were used to collect information on combat veterans 
who have served during Operation Iraqi Freedom (OIF), Operation Enduring Freedom (OEF), 
and Operation New Dawn (OND). The Comprehensive Traumatic Brain Injury Evaluation 
(CTBIE) database includes combat veterans who have served in the Iraq and Afghanistan, 
separated from the military, enrolled in the VHA healthcare system, and received a 
comprehensive TBI evaluation. The National Patient Care Database (NPCD) includes other 
combat veterans enrolled in the VHA healthcare system who have received inpatient or 
outpatient TBI diagnoses as part of routine clinical care. Definitions and criteria for the 
psychological disorders mentioned in this paper were taken from the Diagnostic and Statistical 
Manual of Mental Disorders, 5th Edition (DSM-5) and the International Statistical Classification 







 The awareness for treatment of traumatic brain injuries has drastically increased over the 
years. Dedicated research centers and rehabilitation centers for both military veterans and 
civilians have popped up across the United States. In order for treatments to be effective, 
researchers and healthcare workers need to understand the structural and neuronal damages and 
changes that the brain endures after sustaining a TBI (McKee & Robinson, 2014). The 
psychological effects need to equally be addressed as well, as research has shown the link 
between TBI and cognitive changes such as PTSD. By addressing the brain injuries and 
psychological stress, healthcare teams can efficiently treat and manage their patients’ symptoms 
both short-term and long-term prognoses (Srinivasan et al., 2019). Rosenfeld et al. (2013) 
suggests the evidence-based clinical practice model to manage mTBI symptoms. They 
recommend a multidisciplinary team approach, using extensive rehabilitation programs, 
cognitive rehabilitation, ophthalmological assessments, periodic neuroimaging to manage the 
progression, and posture and gait assessments, and retraining if the soldiers need it (Rosenfeld et 
al., 2013). The benefit to a multidisciplinary approach allows for complete management of 
symptoms and to watch for any neurodegeneration. The quicker the team can determine if any 
neurodegenerative disease is present, the sooner they can begin treatments to help prevent further 
damage or disease progression. 
 Fluorodeoxyglucose-positron emission tomography (FDG-PET) has become useful in 
research studies by Peskind et al (2011). FDG-PET imaging allows researchers to measure 




associated neurobiological substrates can signify certain somatic, cognitive, and behavioral 
symptoms that are commonly reported by veterans from the Iraq and Afghanistan conflicts. The 
ability to track and measure neurobiological substrates via the FDG-PET imaging can play a 
significant role in diagnosis and treatment. The ability to use imaging tools in help diagnose and 
treat TBI patients will drastically improve care in addition to what is already deemed standard 
care. Healthcare teams typically use several factors such as injury severity, the initial GCS given 
in the field, age, medical comorbidities, and any associated injuries to establish a plan of care. As 
treatment progresses, they will monitor the patient’s response to therapy and adjust the protocols 
based upon the type of TBI sustained, either global or focal injury (Srinivasan et al., 2019).  
 The ability to test for neuro-biomarkers will significantly improve the approach to 
diagnosing TBIs and the associated treatment plans. Not only will treatments improve, but 
healthcare teams will also be able to assess and monitor the progression of the injury in real time, 
adjusting care as needed. Currently, there are no objective biomarkers that can pinpoint exact 
symptoms and injury progression, yet researchers have begun to focus on a few biomarkers that 
have been consistently associated with traumatic brain injuries and neuronal damage: GFAP, 
NfL, S-100ß, tau, MBP, and UCH-L1. GFAP, otherwise known as glial fibrillary acidic protein, 
is an intermediate filament protein expressed by astrocytes in the central nervous system that 
typically marks the mechanical strength of cells (Okonkwo et al., 2013). Researchers have 
hypothesized that when there is astrocyte brain damage due to a TBI, GFAP is able to cross the 
disrupted blood-brain barrier and become detected in the peripheral blood. Okonkow et al. 
(2013) found an association between the levels of plasma GFAP and the Glasgow Coma Scale 
scores. The serum levels of GFAP increased as the GCS scores decreased, and these elevated 




addition, Yue et al. (2019) found that the plasma levels of GFAP in patients after sustaining a 
TBI correlated with the intracranial injury shown on CT scans. The researchers concluded that 
GFAP would be a great diagnostic tool to help early detection of TBI and determine whether 
more imaging is necessary for each patient. UCH-L1, otherwise known as ubiquitin C-terminal 
hydrolase L1, is a degradation enzyme expressed specifically by neurons in the brain. UCH-L1 is 
able to cross the disrupted blood-brain barrier when there is neuronal damage after a sustained 
TBI. Researchers have found elevated blood levels of UCH-L1 during the acute phase of a TBI 
as well as in severe TBI cases (Shahim et al., 2020; Yue et al., 2019). Tau is a protein associated 
with the structural stability of microtubules of unmyelinated axons in the central nervous system. 
Similar to UCH-L1 and GFAP, tau is able to cross the disrupted blood-brain barrier as a result of 
neuronal damage caused by a TBI. Although Shahim et al. (2020) found elevated blood levels of 
tau in patients with a TBI, there was no significant correlation to severity, outcome, or imaging. 
Since tau is associated with neurodegenerative diseases, the researchers concluded that the 
accumulation of tau as a result of a TBI can contribute to the progression of those diseases. 
While UCH-L1 and GFAP have been shown to be useful diagnostic biomarkers, NfL has 
become an increasingly popular and more effective diagnostic marker. NfL, otherwise known as 
neurofilament light chain protein, is a structural component of the cytoskeletons of axons. NfL is 
typically expressed in large myelinated subcortical axons, which are vulnerable to breakdown 
during a TBI event (Shahim et al., 2020). Damage to the cytoskeleton of these subcortical axons 
allows NfL to become detected in the peripheral blood, crossing the disrupted blood-brain barrier 
like GFAP and UCH-L1. Shahim et al. (2020) found that blood levels of NfL can help healthcare 
teams determine the severity of the TBI, whether mild, moderate or severe, and can help serve as 




RECOMMENDATIONS FOR FUTURE STUDIES 
 
 As mentioned in the Discussion, the continued research into biomarkers that can help 
identify and target treatments for soldiers diagnosed with a TBI is crucial. The more biomarkers 
and the more information we have about what they mean cellularly and physiologically can help 
rehabilitation programs individualize their programs and the soldier’s needs. These neuro-
biomarkers can dramatically help in the initial assessments of TBI, becoming a diagnostic tool to 
help confirm any abnormalities in neuroimaging and head CT scans (Yue et al., 2019). The fact 
that a simple blood test can tell a wealth of knowledge can hopefully be implemented in the 
future to combat zones. Combat medics overseas would be able to test right then and there in the 
field, and quickly diagnose and provide first-line treatment rather than have time pass to truly 
diagnose a TBI. In addition to serum biomarkers, future studies must look into specific 
rehabilitation treatments to aid in a more complete and increased recovery. Such protocols 
should include restorative practices that focus on the mechanisms that help promote and build 
neuroplasticity like addressing sleep needs, exercise, and nutrition (McKee & Robinson, 2014). 
Pharmacological agents should be researched and trialed to help reduce any cognitive deficits in 
solders sustaining a TBI, especially soldiers who are constantly suffering from PTSD and 
suicidal tendencies. These therapeutic agents should take a holistic approach to treating the 
soldiers, providing care for the structural damages from the TBI itself and also the invisible 
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